55.4
Traws Pharma, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
39.3
FY23:
22.7
FY24:
25.0
FY25:
7.98
(positive)
Change from FY21 to FY25
millions USD
FY21:
0.05
FY22:
0.03
FY23:
0.02
FY24:
0.01
FY25:
2.64
Total assets
Change from FY21 to FY25
millions USD
FY21:
55.5
FY22:
39.4
FY23:
22.7
FY24:
25.0
FY25:
10.6
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
6.12
FY22:
8.05
FY23:
9.22
FY24:
11.5
FY25:
11.1
(negative)
Change from FY21 to FY25
millions USD
FY21:
3.24
FY22:
3.02
FY23:
2.79
FY24:
45.1
FY25:
0.10
(positive)
Change from FY21 to FY25
millions USD
FY21:
46.1
FY22:
28.3
FY23:
10.7
FY24:
−31.6
FY25:
−0.63
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
55.5
FY22:
39.4
FY23:
22.7
FY24:
25.0
FY25:
10.6
All amounts in millions USD